Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
